long-term low-dose Natural IFN-alpha for patients with chronic hepatits C

long-term low-dose Natural IFN-alpha for patients with chronic hepatits C - GLSG,2005.Sumiferon

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000228

Enrollment

Registered

2005-09-13

Start date

2004-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis C

Interventions

intervention:Sumiferon control:SNMC

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 patients who agreeed with this study pretreatment is insufficient 2 positive test for HCV-RNA, abnormal ALT

Exclusion criteria

Exclusion criteria: 1 Allergy to IFN or cow-derived substances 2 Allergy to biological products such as vaccine 3 essential to administration of sho- saiko-to 4 liver diseases with other causes such as autoimmune hepatitis, alcoholic hepatitis 5 patients with previously-diagnosed HCC 6 Leucopenia(less than 2000) or thrombopenia (less than 50000) 7 central nerve sytem manifestation or psychosomatic disorders 8 severe complications 9 during pregnancy or lactation 10 inappropriate subjects judged by physicinas 11 patients hoping for certain therapeutic methods

Design outcomes

Primary

Measure	Time frame
liver function-transaminase virological response	—

Secondary

Measure	Time frame
Incidence of hepatocellular carcinoma safety	—

Countries

Japan

Contacts

Public ContactKen Sato

Gunma University Graduate School of Medicine Department of Medicine and Molecular Science

satoken@showa.gunma-u.ac.jp027-220-8127

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026